Yakup Ergün/obdh.com.tr
May 26, 2024, 13:42
Some of the highlights while waiting for ASCO24 by Yakup Ergün
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared a post on X:
“Some of the highlights while waiting for ASCO24
Ab 1005
Enfortumab vedotin in TNBC and HR+/HER2– breast cancer (BC) cohorts of EV-202.
64% of patients with TNBC received ≥2L systemic tx, 73% of HR+ patients received ≥3L
ORR TNBC – %19
HR+ – 15.6%”
View the article attached to the post.
Source: Yakup Ergün/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 15, 2025, 18:57
Apr 15, 2025, 18:26
Apr 15, 2025, 17:49
Apr 15, 2025, 17:41